Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Clinical trial results in RA reported for T-614

July 9, 1998

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

Bone-sparing antiinflammatory benzamide under investigation at Daiichi

July 9, 1998

Vertex/Kissei select development candidate from p38 MAP kinase inhibitor program

July 8, 1998

Long-term safety and efficacy data presented for Enbrel

July 8, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

Boston Life Sciences submits further data supporting Therafectin NDA

July 3, 1998

Additional phase III results reported for Cypress Bioscience's Prosorba Column

July 1, 1998

Celltech scientists discover potent and selective inhibitors of protein kinases

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...